Home >
Law >
Antitrust / Competition Law >
Antitrust Policy in Health Care Markets

Antitrust Policy in Health Care Markets

Author: Roger D. Blair; Christine Piette Durrance; Tirza J. Angerhofer
Publisher: Cambridge University Press
ISBN: 9781009096492

Published In: December 2022
Format: Paperback
Jurisdiction: U.K. ? Disclaimer:
Countri(es) stated herein are used as reference only
Hardback Edition ISBN: 9781316515204

List Price: HKD 572.00

HKD 554.84 Save HKD 17.16 (3%)

Download Order Form

Add to Wishlist
| Add to Compare

Description
Contents

Details

Health care costs in the United States are much higher than in other countries. These cost differences can be explained in part by a lack of competition in the United States. Some markets, such as pharmaceuticals and medical equipment, have elements of monopoly. Other markets, such as health insurance, have elements of monopsony. Many other markets may be subject to collusion on prices, such as generic drugs, or wages, such as the nurse labor market. Lawful monopoly and monopsony are beyond the reach of antitrust laws, but collusion is not. When appropriate, vigorous antitrust enforcement challenging anticompetitive conduct can aid in reducing health care costs. This book addresses monopoly, monopsony, cartels of sellers and buyers, horizontal and vertical merger policy, and antitrust enforcement through private suits as well as the efforts of the antitrust Agencies. The authors demonstrate how enforcing antitrust laws can ultimately promote competition and reduce health care costs.

1. Health care markets and competition policy

2. Antitrust policy in the United States

Section I. Monopoly:

Patents and monopoly pricing of pharmaceuticals

4. Patents and exclusionary product hopping

5. Bundled discounts and peace health

Section II. Seller Cartels:

6. Collusion in health care markets

7. Collusion in generic drug markets

8. The hatch-waxman act, patent infringement suits, and reverse payments

Appendix

The economics of settlements